Stock Report

Astec LifeSciences Ltd Q4 FY2026 consolidated loss at Rs. 7.75 crores

Posted On : 2026-04-28 12:34:29( TIMEZONE : IST )

Astec LifeSciences Limited has reported Consolidated financial results for the period ended March 31, 2026.

Financial Results (Q4 FY2026) - QoQ Comparison

The company has reported total income of Rs. 161.2562 crores during the period ended March 31, 2026 as compared to Rs. 125.5355 crores during the period ended December 31, 2025.

The company has posted net profit / (loss) of Rs. -7.7573 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. -15.6954 crores for the period ended December 31, 2025.

The company has reported EPS of Rs. -3.48 for the period ended March 31, 2026 as compared to Rs. -7.04 for the period ended December 31, 2025.

Financials	Q4 FY2026	Q3 FY2026	% Change
Total Income	₹ 161.2562 crs	₹125.5355 crs	28.45%
Net Profit	₹-7.7573 crs	₹-15.6954 crs	50.58%
EPS	₹-3.48	₹-7.04	50.57%

Financial Results (Q4 FY2026) - YoY Comparison

The company has reported total income of Rs. 161.2562 crores during the period ended March 31, 2026 as compared to Rs.120.3182 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs.-7.7573 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.-16.0876 crores for the period ended March 31, 2025.

The company has reported EPS of Rs.-3.48 for the period ended March 31, 2026 as compared to Rs.-8.20 for the period ended March 31, 2025.

Financials	Q4 FY2026	Q4 FY2025	% Change
Total Income	₹ 161.2562 crs	₹120.3182 crs	34.02%
Net Profit	₹-7.7573 crs	₹-16.0876 crs	51.78%
EPS	₹-3.48	₹-8.20	57.56%

Financial Results (Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.453.2165 crores during the Financial Year ended March 31, 2026 as compared to Rs.386.9322 crores during the Financial Year ended March 31, 2025.

The company has posted net profit / (loss) of Rs.-80.9175 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.-134.7524 crores for the Financial Year ended March 31, 2025.

The company has reported EPS of Rs.-37.79 for the Financial Year ended March 31, 2026 as compared to Rs.-68.71 for the Financial Year ended March 31, 2025.

Financials	Year Ended FY2026	Year Ended FY2025	% Change
Total Income	₹453.2165 crs	₹386.9322 crs	17.13%
Net Profit	₹-80.9175 crs	₹-134.7524 crs	39.95%
EPS	₹-37.79	₹-68.71	45.00%

Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 749.00 as compared to the previous close of Rs. 722.50. The total number of shares traded during the day was 5787 in over 340 trades.

The stock hit an intraday high of Rs. 769.00 and intraday low of 715.60. The net turnover during the day was Rs. 4313829.00.